Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Comparison of FASTlab 18F-FDG production using phosphate and citrate buffer cassettes.

Long JZ, Jacobson MS, Hung JC.

J Nucl Med Technol. 2013 Mar;41(1):32-4. doi: 10.2967/jnmt.112.112649. Epub 2013 Jan 14.

2.

Stability evaluation of (18)F-FDG at high radioactive concentrations.

Walters LR, Martin KJ, Jacobson MS, Hung JC, Mosman EA.

J Nucl Med Technol. 2012 Mar;40(1):52-6. doi: 10.2967/jnmt.111.097287. Epub 2012 Feb 7.

3.

Fully automated [18F]fluorocholine synthesis in the TracerLab MX FDG Coincidence synthesizer.

Kryza D, Tadino V, Filannino MA, Villeret G, Lemoucheux L.

Nucl Med Biol. 2008 Feb;35(2):255-60. doi: 10.1016/j.nucmedbio.2007.11.008.

PMID:
18312837
4.

Radiolysis of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG) and the role of ethanol and radioactive concentration.

Jacobson MS, Dankwart HR, Mahoney DW.

Appl Radiat Isot. 2009 Jun;67(6):990-5. doi: 10.1016/j.apradiso.2009.01.005. Epub 2009 Jan 21.

PMID:
19231219
5.

Formulation of (18)F-FDG: pH adjustment of buffered solution.

Martinez T, Leiva L.

J Nucl Med Technol. 2012 Mar;40(1):48-9. doi: 10.2967/jnmt.111.092825. Epub 2012 Jan 25.

6.

Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging.

Prager E, Wehrschuetz M, Bisail B, Woltsche M, Schwarz T, Lanz H, Sorantin E, Aigner RM.

Nuklearmedizin. 2008;47(1):18-23.

PMID:
18278208
7.

[Influence of radioactive concentration and storage time on radiochemical purity of 18F-FDG].

Jiménez Romero IR, Roca Engronyat M, Campos Añón F, Cordero Ramajo J, Liarte Trías I, Benítez Segura A, Bajén Lázaro M, Ferrán Sureda N, Puchal Añé R, Gámez Cenzano C.

Rev Esp Med Nucl. 2006 Jan-Feb;25(1):20-5. Spanish.

8.

Fast and repetitive in-capillary production of [18F]FDG.

Wester HJ, Schoultz BW, Hultsch C, Henriksen G.

Eur J Nucl Med Mol Imaging. 2009 Apr;36(4):653-8. doi: 10.1007/s00259-008-0985-9. Epub 2008 Nov 27.

PMID:
19037638
9.

Measurement of long lived radioactive impurities retained in the disposable cassettes on the Tracerlab MX system during the production of [18F]FDG.

Ferguson D, Orr P, Gillanders J, Corrigan G, Marshall C.

Appl Radiat Isot. 2011 Oct;69(10):1479-85. doi: 10.1016/j.apradiso.2011.05.028. Epub 2011 May 30.

PMID:
21641809
10.

Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.

McLarty K, Moran MD, Scollard DA, Chan C, Sabha N, Mukherjee J, Guha A, McLaurin J, Nitz M, Houle S, Wilson AA, Reilly RM, Vasdev N.

Nucl Med Biol. 2011 Oct;38(7):953-9. doi: 10.1016/j.nucmedbio.2011.02.017. Epub 2011 May 6.

PMID:
21982567
11.

The automatic production of 16alpha-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system.

Oh SJ, Chi DY, Mosdzianowski C, Kil HS, Ryu JS, Moon DH.

Appl Radiat Isot. 2007 Jun;65(6):676-81. Epub 2006 Sep 11.

PMID:
16963265
12.

[Synthesis of 18F-FDG with FDG MicroLab system: basic studies for clinical application].

Kuge Y, Tsukamoto E, Katoh C, Seki K, Ohkura K, Ohmiya Y, Nishijima K, Tanaka A, Sasaki M, Tamaki N.

Kaku Igaku. 1999 Oct;36(8):873-8. Japanese.

PMID:
10586548
13.

Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis.

Herrmann K, Ott K, Buck AK, Lordick F, Wilhelm D, Souvatzoglou M, Becker K, Schuster T, Wester HJ, Siewert JR, Schwaiger M, Krause BJ.

J Nucl Med. 2007 Dec;48(12):1945-50. Epub 2007 Nov 15.

14.

Studies of the solubility of different calcium phosphate ceramic particles in vitro.

Klein CP, de Blieck-Hogervorst JM, Wolke JG, de Groot K.

Biomaterials. 1990 Sep;11(7):509-12.

PMID:
2242400
15.

Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas.

Yamane T, Daimaru O, Ito S, Yoshiya K, Nagata T, Ito S, Uchida H.

J Nucl Med. 2004 Nov;45(11):1838-42.

16.

18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.

Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, Dhurairaj T, Dadparvar S, Alavi A.

J Nucl Med. 2004 Nov;45(11):1796-803.

17.

Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.

Ito S, Kato K, Ikeda M, Iwano S, Makino N, Tadokoro M, Abe S, Nakano S, Nishino M, Ishigaki T, Naganawa S.

J Nucl Med. 2007 Jun;48(6):889-95. Epub 2007 May 15.

18.

Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.

Liao S, Penney BC, Wroblewski K, Zhang H, Simon CA, Kampalath R, Shih MC, Shimada N, Chen S, Salgia R, Appelbaum DE, Suzuki K, Chen CT, Pu Y.

Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):27-38. doi: 10.1007/s00259-011-1934-6. Epub 2011 Sep 23.

PMID:
21946983
19.

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.

Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.

PMID:
21231796
20.

Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.

Phi JH, Paeng JC, Lee HS, Wang KC, Cho BK, Lee JY, Park SH, Lee J, Lee DS, Kim SK.

J Nucl Med. 2010 May;51(5):728-34. doi: 10.2967/jnumed.109.070920. Epub 2010 Apr 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk